1、1 ()ACBE - -(1)(2)(3)(4)2-3-4?60g?3-4 30g15g1/24-620g30g1/2 4-630g30g1/13-4 -?- -.-1 2 3 -10%16%20451193-16028%2403-456789101112-34%50%10%51 -2 -3 -4 5 6 7 B-3550%90%-?121503020151012612011-286.82301051?-1/5-?(1)(2)(3)-(4)?(1) (2) (3) 39BB?B-70%- -?1.5cm-(Dormia)-X?-:- - - - 474- 15.4%(1)(2)(3)(4)(5
2、)1 - -1972Danjinger4 2cmX 15mg/g6243070% B13 -325% Rowacholmetronidazole1985 -2-PTC3 ESWL 1984Lauerbwchextracorporeal shock wave-lithotripsyESWLEDAP LT-013204mm75mm9107PZ 1.252.5/sec100%6075B 1215mm 31520mm119881EDAP-LT 0168798%1234627%33%40% 45%50%45%16%UDCA8mg/kg/d-11.2%4-5- 61 23 4:1. 2. 3. CT 4. -ERCP5. -PTC 6. EUS 7. MRCP8. CT 9. :1-2AC3-45-
